Special Issue "Omic Approaches in Human Disease: Impact on Therapeutics and Diagnostics"
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Bioinformatics and Systems Biology".
Deadline for manuscript submissions: closed (31 December 2022) | Viewed by 23778
Special Issue Editors
Interests: molecular mechanisms of neurodegeneration and cancer; autophagy; disease biomarkers; gene editing; omics; mitochondrial dysfunction in neurological diseases
Special Issues, Collections and Topics in MDPI journals
Interests: omics; bioinformatics; neurosciences; in vitro disease models; biomarker discovery; bioenrgetics; mitochondrial disorders
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are pleased to invite you to participate in our Special Issue on “Omics Approaches in Human Disease: Impact on Therapeutics and Diagnostics” which is being prepared for the journal Biomolecules.
This Special Issue will focus on the application of omics strategies to characterize pathological conditions in human diseases, also facilitating diagnosis and therapeutic intervention.
Omics has become the new mantra in molecular research, allowing a dynamic investigation of the molecular basis underlying onset and progression of a wide variety of complex human diseases, including cancer and neurodegeneration. Omics technologies are paving the way to biomarker discovery, identification of disease-associated signaling molecules, as well as cellular metabolism and early detection of cancer, impacting both our understanding of biological processes and new diagnostic or intervention strategies. Moreover, advanced computational science provides increasing power and capacities of omics data acquisition, also enabling integrative studies for a multilevel analysis.
This Special Issue aims to collect papers recounting omics approaches in order to provide new insights into altered pathways and biochemical disease-related processes, increasing our understanding of pathogenesis to identify specific biomarkers of disease status, progression, or therapeutic response.
Original research manuscripts and reviews dealing with these specific aspects are very welcome.
Dr. Federica Morani
Dr. Stefano Doccini
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- omics
- disease biomarkers
- bioinformatics
- biochemical pathways
- diagnostic and therapeutic targets